Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 5;11(1):172.
doi: 10.1186/s40168-023-01616-9.

Arula-7 powder improves diarrhea and intestinal epithelial tight junction function associated with its regulation of intestinal flora in calves infected with pathogenic Escherichia coli O1

Affiliations

Arula-7 powder improves diarrhea and intestinal epithelial tight junction function associated with its regulation of intestinal flora in calves infected with pathogenic Escherichia coli O1

Hao Chen et al. Microbiome. .

Abstract

Background: The effects of Arula-7 powder (ASP) on diarrhea and intestinal barrier function associated with its regulation of intestinal microflora in calves infected with pathogenic Escherichia coli O1 (E. coli O1) were studied.

Method: Twenty Holstein calves were randomly divided into four treatment groups: normal control (NC), model control (MC), 0.5 mg/kg ciprofloxacin (CIP) and 2.50 g/kg ASP groups.

Results: ASP inhibited the relative abundance of Proteobacteria, Selenomonadales, and Enterobacteriales, and increased the relative abundance of Lactobacillus, Faecalibacterium, and Alloprevotella. Moreover, we demonstrated for the first time that the ASP and CIP promoted weight gain, reduced the diarrhea rate (P < 0.05), and enhanced antioxidant capacity (P < 0.05) due to the increase in average daily gain (ADG), total protein (TP), and albumin (ALB). In addition, ASP and CIP increased the expression of Zunola occludens-1 (ZO-1), Occludin, and Claudin-1 in the ileum (P < 0.05), and improved immunity due to increase levels of interleukin-2 (IL-2), interleukin-4 (IL-4), interferon-γ (IFN-γ), immunoglobulin A (IgA), and immunoglobulin G (IgG) in the serum, strengthened CD4+T levels in the ileal mucosa and reducing CD8+T and CD11c+T (P < 0.05).

Conclusion: Hence, The intestinal microbiota environment formed by early intervention of ASP powder has a protective effect on the intestinal mucosal function of calves infected with pathogenic E. coli. Video Abstract.

Keywords: Arula-7 powder; Calf; Diarrhea; Intestinal barrier function; Intestinal flora; Pathogenic Escherichia coli O1.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Effect of ASP on the composition of cecal and colonic contents microbiota in calves infected with pathogenic E. coli O1. Graph A ~ C represents the OTUs at different taxonomical levels in the contents of the cecal: phylum, Order, and Genus. Graph D ~ F represents the OTUs at different taxonomical levels in the contents of the colonic: phylum, Order, and Genus. Red Latin indicates a significant increase (P < 0.05), and blue indicates a significant decrease (P < 0.05)
Fig. 2
Fig. 2
Effect of Arula-7 powder on the composition of rectal microbiota in calves infected with pathogenic E. coli O1. A Graph represents the OTUs at different taxonomical levels: phylum (n = 5). B Graph represents the OTUs at different taxonomical levels: order (n = 5). C The change in the relative abundance of phylum Firmicutes, Bacteroidetes, Fusobacteria, and Actinobacteria. D The ratio of Firmicutes/Bacteroidetes was significantly low in 2.50 g/kg ASP group. E The change in the relative abundance of genus Faecalibacterium, Fusobacterium, Alloprevotella, Megamonas, and Bacteroides. Metastats analysis was applied to identify the significantly differentially abundant phylum and genera among groups. Different letters above the bars denotes significantly differentially abundant genera among groups. (P < 0.05). n = 5
Fig. 3
Fig. 3
Effect of ASP on blood biochemical indexes of calves with E. coli diarrhea. A BUN, blood urea nitrogen. B AST, aspartate aminotransferase. C TP, serum total protein. D ALB, albumin. E ALP, alkaline phosphatase. F Glu, glutamic. n = 5. In the same histogram, the values with the same letter superscripts mean no significant difference (P > 0.05), while with different letter superscripts mean significant difference (P < 0.05)
Fig. 4
Fig. 4
Effects of ASP on histopathological changes of jejunum and ileum with H&E staining (original magnification of 100 ×). A Stroke-physiological saline solution + NC group, B E. coli O+ MC group, C E. coli O+ 0.5 mg/kg CIP group, D E. coli O1 + 2.50 g/kg ASP group
Fig. 5
Fig. 5
Intestinal tight junction proteins in pathogenic E. coli O1 induced diarrhea calf with ASP and CIP for 7 days (400 ×). Immunofluorescence staining of (A) ZO-1, (B) Occludin, and (C) Claudin-1 in the ileum. D, E, F Each field of ZO-1, Occludin, and Claudin-1 from every group was quantified by using ImageJ. Scale bar = 20 μm; red, ZO-1, Occludin, and Claudin-1; blue, 4,6-diamidino-2-phenylindole counterstaining of the nuclei. Control group was denoted as CG; NC, Normal control group; MC, E. coli group; CIP, Ciprofloxacin group; ASP, Arula-7 powder group. ZO-1, Occludin and Claudin-1
Fig. 6
Fig. 6
Intestinal lymphocyte surface molecular proteins in pathogenic E. coli O1 induced diarrhea calf with ASP and CIP for 7 days (400 ×). Immunofluorescence staining of A CD4+, B CD8+, and C CD11c+ in the ileum. D, E, F Each field of CD4+, CD8+, and CD11c+ from every group was quantified by using Image J. G The ratio of CD4+/CD8+T was significantly high in ASP group. Scale bar = 20 μm; red, CD4+, CD8+, and CD11c+; blue, 4,6-diamidino-2-phenylindole counterstaining of the nuclei. Control group was denoted as CG; NC, Normal control group; MC, E. coli group; CIP, Ciprofloxacin group; ASP, Arula-7 powder group
Fig. 7
Fig. 7
Effects of ASP treatment on calf immune markers. The levels of A serum IgA, B serum IgG, C serum SIgA, D serum IL-4, E serum IL-2, F serum IFN-γ, G serum IL-6, H serum TNF-α

References

    1. Mirhoseini A, Amani J, Nazarian S. Review on pathogenicity mechanism of enterotoxigenic Escherichia coli and vaccines against it. Microb Pathog. 2018;117:162–169. - PubMed
    1. Baumgartner M, Bayer F, Pfrunder-Cardozo KR, Buckling A, Hall AR. Resident microbial communities inhibit growth and antibiotic-resistance evolution of Escherichia coli in human gut microbiome samples. PLoS Biol. 2020;18:e3000465. - PMC - PubMed
    1. Liu LL, Wu W, Zhang JY, Lv P, Xu L, Yan YC. Progress of research on the toxicology of antibiotic pollution in aquatic organisms. Acta Ecol Sin. 2018;38(1):36–41.
    1. Li Q, Montalban-Lopez M, Kuipers OP. Increasing the antimicrobial activity of Nisin-based Lantibiotics against Gram-negative pathogens. Appl Environ Microbiol. 2018;84(12):e00052–e118. - PMC - PubMed
    1. Yang Y, Gang C, Qian Y, Ye J, Cai XT, Tsering P, et al. Gut microbiota drives the attenuation of dextran sulphate sodium-induced colitis by Huangqin decoction. Oncotarget. 2017;8(30):48863–48874. - PMC - PubMed

Publication types